CEO of company that controversially hiked price of life-saving E - KWWL - Eastern Iowa Breaking News, Weather, Closings

CEO of company that controversially hiked price of life-saving EpiPens also saw her salary jump - from $2m to $19m

Posted: Updated:

The CEO of EpiPen company Mylan not only quadrupled the price of the life-saving allergy tool , she also started taking home 671% more money.

Mylan is under fire for increasing the price of EpiPens from $56.64 per pen in 2007 to $317.82 in 2015...that is an increase of 461%.

What could be viewed as even more shocking is the fact that many of Mylan's executives saw huge increases during that period.  Including Heather Bresch, the CEO, whose pay went from just under $2.5 million to nearly $19 million.

This after nine years of gradually increasing the price of the EpiPen, which gives lifesaving shots of epinephrine to those suffering dangerous allergic reactions.

Iowa Senator Chuck Grassley has written the company complaining about the high costs for parents and schools and demanding an explanation.  In a statement, Mylan said most customers have insurance that limits their co-payments, or they can use a copay discount card to save $100. It recommended people review their coverage.

Powered by Frankly